We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Feil Family Brain & Mind Research Institute

You are here

Ketamine reverses neural changes underlying depression.

In a study published in Science 12 April 2019, Dr. Conor Liston and teams of scientists have identified that ketamine-induced changes in the brain are responsible for the remission of depression in mice. These findings may help researchers develop interventions that promote lasting remission of depression in humans.

For more information:
https://news.weill.cornell.edu/news/2019/04/study-shows-how-ketamine-reverses-depression—and-how-its-benefits-could-be-extended

https://news.cornell.edu/stories/2019/04/ketamines-short-term-relief-depression-could-be-extended-researchers-find

https://www.nih.gov/news-events/news-releases/ketamine-reverses-neural-changes-underlying-depression-related-behaviors-mice

Weill Cornell Medicine Feil Family Brain & Mind Research Institute 407 E 61st St New York, NY 10065 Phone: (646) 962-8277 Fax: (646) 962-0535